Restless legs syndrome market is projected to grow at a CAGR of 6.2% during the forecast period. The increase in the prevalence of restless legs syndrome (RLS) is a key factor responsible for the growth of the market. RLS is a disorder that is associated with the part of the nervous system that causes patients an urge to move the legs restlessly. According to the estimation of the National Institute of Neurological Disorders and Stroke (NIH), around 7-10 % of the US population has RLS. Moreover, the rising geriatric population further boosts the growth of the global market. As per the UN (United Nations), by 2050 around 1 in 6 (16%) citizens will be over the age of 65 years, globally, which was 1 in 11 (9%) in 2019. Old age, obesity, and snoring conditions lead to an increase in the rate of various types of sleep disorders which will create significant demand for diagnosis and treatment for obstructive sleep-wake disorders shortly.
However, the high cost of drugs and therapy used for the treatment of restless leg syndrome coupled with low healthcare budget in some developing countries may hinder the growth of the market. For instance, the annual cost of Rotigotine (Neupro), a drug to treat used to treat restless legs syndrome and periodic limb movement disorder can cost up to $5,300 per year in the US. Huge R&D expenditure by market players for the development of the novel intervention is anticipated to create a considerable opportunity for market growth.
To Request a Sample of our Report on Restless Legs Syndrome Market: https://www.omrglobal.com/request-sample/restless-legs-syndrome-market
Restless Leg Syndrome Market Segmentation
By Treatment
- Medication
- Therapy
- Devices
By End-User
- Hospitals
- Homecare
- Others
A full Report of Restless Legs Syndrome Market is Available @ https://www.omrglobal.com/industry-reports/restless-legs-syndrome-market
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Company Profiles
- Akorn, Inc.
- Arbor Pharmaceuticals, LLC
- Boehringer Ingelheim GmbH
- GlaxoSmithKline plc
- Glenmark Pharmaceuticals Ltd.
- Jazz Pharmaceuticals plc
- Kyowa Hakko Kirin Co. Ltd.
- LGM Pharma
- Mallinckrodt Pharmaceuticals
- Merck Co, Inc.
- Mylan N.V.
- Pfizer, Inc.
- Serina Therapeutics, Inc.
- Teva Pharmaceutical Industries, Ltd.
- UCB S.A.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404